Amedeo Smart

Free Medical Literature Service


 

Amedeo

Influenza

  Free Subscription

Articles published in
J Gen Virol
    July 2022
  1. SHARTOUNY JR, Lowen AC
    Message in a bottle: mRNA vaccination for influenza.
    J Gen Virol. 2022;103.
    >> Share

    June 2022
  2. LIU L, Weiss A, Saul VV, Schermuly RT, et al
    Comparative kinase activity profiling of pathogenic influenza A viruses reveals new anti- and pro-viral protein kinases.
    J Gen Virol. 2022;103.
    >> Share

    May 2022
  3. DE MOOR WRJ, Regnard GL, Rybicki EP, Williamson AL, et al
    Characterization of a dynamic self-replicating mammalian expression vector based on the circular ssDNA genome of beak and feather disease virus.
    J Gen Virol. 2022;103.
    >> Share

    April 2022
  4. THAKUR N, Gallo G, Newman J, Peacock TP, et al
    SARS-CoV-2 variants of concern alpha, beta, gamma and delta have extended ACE2 receptor host ranges.
    J Gen Virol. 2022;103.
    >> Share

    March 2022
  5. DOLINSKI AC, Homola JJ, Jankowski MD, Robinson JD, et al
    Differential gene expression reveals host factors for viral shedding variation in mallards (Anas platyrhynchos) infected with low-pathogenic avian influenza virus.
    J Gen Virol. 2022;103.
    >> Share

    November 2021
  6. SEALY JE, Howard WA, Molesti E, Iqbal M, et al
    Amino acid substitutions in the H5N1 avian influenza haemagglutinin alter pH of fusion and receptor binding to promote a highly pathogenic phenotype in chickens.
    J Gen Virol. 2021;102.
    >> Share

  7. ORR-BURKS N, Murray J, Todd KV, Bakre A, et al
    MicroRNAs affect GPCR and Ion channel genes needed for influenza replication.
    J Gen Virol. 2021;102.
    >> Share

  8. VIANA K, Zarpelon L, Leandro A, Terencio M, et al
    Infection in asymptomatic carriers of SARS-CoV-2 can interfere with the achievement of robust immunity on a population scale.
    J Gen Virol. 2021;102.
    >> Share

  9. SZYMCZAK A, Jedruchniewicz N, Torelli A, Kaczmarzyk-Radka A, et al
    Antibodies specific to SARS-CoV-2 proteins N, S and E in COVID-19 patients in the normal population and in historical samples.
    J Gen Virol. 2021;102.
    >> Share

    October 2021
  10. HUSSAIN S, Daniels RS, Wharton SA, Howell S, et al
    Reduced sialidase activity of influenza A(H3N2) neuraminidase associated with positively charged amino acid substitutions.
    J Gen Virol. 2021;102.
    >> Share

  11. MHAMDI Z, Carbonneau J, Venable MC, Baz M, et al
    Replication and transmission of an influenza A(H3N2) virus harboring the polymerase acidic I38T substitution, in guinea pigs.
    J Gen Virol. 2021;102.
    >> Share

  12. OLBRICH L, Castelletti N, Schalte Y, Gari M, et al
    Head-to-head evaluation of seven different seroassays including direct viral neutralisation in a representative cohort for SARS-CoV-2.
    J Gen Virol. 2021;102.
    >> Share

    September 2021
  13. STALLER E, Sheppard CM, Baillon L, Frise R, et al
    A natural variant in ANP32B impairs influenza virus replication in human cells.
    J Gen Virol. 2021;102.
    >> Share

    August 2021
  14. HIRST JC, Hutchinson EC
    Corrigendum: Single-particle measurements of filamentous influenza virions reveal damage induced by freezing.
    J Gen Virol. 2021;102.
    >> Share

  15. RAHMAN F, Libre C, Oleinikov A, Tcherniuk S, et al
    Chloroquine and pyrimethamine inhibit the replication of human respiratory syncytial virus A.
    J Gen Virol. 2021;102.
    >> Share

    July 2021
  16. POHL MO, Busnadiego I, Marrafino F, Wiedmer L, et al
    Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir.
    J Gen Virol. 2021;102.
    >> Share

    June 2021
  17. ELGENDY EM, Arai Y, Kawashita N, Isobe A, et al
    Double mutations in the H9N2 avian influenza virus PB2 gene act cooperatively to increase viral host adaptation and replication for human infections.
    J Gen Virol. 2021;102.
    >> Share

  18. CHAPPELL JG, Tsoleridis T, Clark G, Berry L, et al
    Retrospective screening of routine respiratory samples revealed undetected community transmission and missed intervention opportunities for SARS-CoV-2 in the United Kingdom.
    J Gen Virol. 2021;102.
    >> Share

    May 2021
  19. DISSANAYAKE TK, Yan B, Ng AC, Zhao H, et al
    Differential role of sphingomyelin in influenza virus, rhinovirus and SARS-CoV-2 infection of Calu-3 cells.
    J Gen Virol. 2021;102.
    >> Share

  20. GOLDEN JW, Zeng X, Cline CR, Garrison AR, et al
    Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.
    J Gen Virol. 2021;102.
    >> Share

  21. ZHANG QY, Deng CL, Liu J, Li JQ, et al
    SARS-CoV-2 replicon for high-throughput antiviral screening.
    J Gen Virol. 2021;102.
    >> Share

    April 2021
  22. HENSS L, Auste A, Schurmann C, Schmidt C, et al
    The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection.
    J Gen Virol. 2021;102.
    >> Share

  23. SMITHER SJ, Eastaugh LS, Findlay JS, Laws TR, et al
    Investigative study into whether an insect repellent has virucidal activity against SARS-CoV-2.
    J Gen Virol. 2021;102.
    >> Share

  24. PEACOCK TP, Penrice-Randal R, Hiscox JA, Barclay WS, et al
    SARS-CoV-2 one year on: evidence for ongoing viral adaptation.
    J Gen Virol. 2021;102.
    >> Share

  25. DAVIES K, Buczkowski H, Welch SR, Green N, et al
    Effective in vitro inactivation of SARS-CoV-2 by commercially available mouthwashes.
    J Gen Virol. 2021;102.
    >> Share

    March 2021
  26. MONCHATRE-LEROY E, Lesellier S, Wasniewski M, Picard-Meyer E, et al
    Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2.
    J Gen Virol. 2021;102.
    >> Share

  27. GUPTA A, Sabarinathan R, Bala P, Donipadi V, et al
    A comprehensive profile of genomic variations in the SARS-CoV-2 isolates from the state of Telangana, India.
    J Gen Virol. 2021;102.
    >> Share

  28. ROE MK, Junod NA, Young AR, Beachboard DC, et al
    Targeting novel structural and functional features of coronavirus protease nsp5 (3CL(pro), M(pro)) in the age of COVID-19.
    J Gen Virol. 2021;102.
    >> Share

  29. AUERSWALD H, Yann S, Dul S, In S, et al
    Assessment of inactivation procedures for SARS-CoV-2.
    J Gen Virol. 2021;102.
    >> Share

  30. SIMMONDS P, Williams S, Harvala H
    Understanding the outcomes of COVID-19 - does the current model of an acute respiratory infection really fit?
    J Gen Virol. 2021;102.
    >> Share

    February 2021
  31. KHALIL AM, Yoshida R, Masatani T, Takada A, et al
    Variation in the HA antigenicity of A(H1N1)pdm09-related swine influenza viruses.
    J Gen Virol. 2021 Feb 22. doi: 10.1099/jgv.0.001569.
    >> Share

  32. CLEMENTS AL, Peacock TP, Sealy JE, Lee HM, et al
    PA-X is an avian virulence factor in H9N2 avian influenza virus.
    J Gen Virol. 2021 Feb 5. doi: 10.1099/jgv.0.001531.
    >> Share

    January 2021
  33. KIM DI, Cho YB, Lim Y, Hong SH, et al
    Chios mastic gum inhibits influenza A virus replication and viral pathogenicity.
    J Gen Virol. 2021 Jan 8. doi: 10.1099/jgv.0.001550.
    >> Share

  34. THAKUR N, Conceicao C, Isaacs A, Human S, et al
    Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell-cell fusion.
    J Gen Virol. 2021;102.
    >> Share

    December 2020
  35. HARRIS M
    Microbiology Society online workshop on SARS-CoV-2 and COVID-19, Wednesday 29 July 2020.
    J Gen Virol. 2020;101:1227-1228.
    >> Share

    November 2020
  36. YU J, Li F, Wang D
    The first decade of research advances in influenza D virus.
    J Gen Virol. 2020 Nov 19. doi: 10.1099/jgv.0.001529.
    >> Share

  37. KLIMSTRA WB, Tilston-Lunel NL, Nambulli S, Boslett J, et al
    SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients.
    J Gen Virol. 2020;101:1156-1169.
    >> Share

    October 2020
  38. LI Y, Chai W, Min J, Ye Z, et al
    Neddylation of M1 negatively regulates the replication of influenza A virus.
    J Gen Virol. 2020 Oct 5. doi: 10.1099/jgv.0.001503.
    >> Share

  39. FIRTH AE
    A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a.
    J Gen Virol. 2020;101:1085-1089.
    >> Share

  40. SILVA SJRD, Germano Mendes RP, Alves da Silva CT, Lorusso A, et al
    Insights into SARS-CoV-2, the Coronavirus Underlying COVID-19: Recent Genomic Data and the Development of Reverse Genetics Systems.
    J Gen Virol. 2020;101:1021-1024.
    >> Share

  41. RENNICK LJ, Nambulli S, Lemon K, Olinger GY, et al
    Recombinant subtype A and B human respiratory syncytial virus clinical isolates co-infect the respiratory tract of cotton rats.
    J Gen Virol. 2020;101:1056-1068.
    >> Share

  42. RIJSBERGEN LC, Rennick LJ, Laksono BM, van Run PRWA, et al
    In vivo comparison of a laboratory-adapted and clinical-isolate-based recombinant human respiratory syncytial virus.
    J Gen Virol. 2020;101:1037-1046.
    >> Share

    September 2020
  43. MOOIJ P, Mortier D, Stammes M, Fagrouch Z, et al
    Aerosolized pH1N1 influenza infection induces less systemic and local immune activation in the lung than combined intrabronchial, nasal and oral exposure in cynomolgus macaques.
    J Gen Virol. 2020 Sep 25. doi: 10.1099/jgv.0.001489.
    >> Share

  44. WANG J, Xu X, Zhou X, Chen P, et al
    Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection.
    J Gen Virol. 2020;101:921-924.
    >> Share

    August 2020
  45. KELLAM P, Barclay W
    The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.
    J Gen Virol. 2020;101:791-797.
    >> Share

    June 2020
  46. ZHANG T, Fan K, Zhang X, Xu Y, et al
    Diversity of avian influenza A(H5N6) viruses in wild birds in southern China.
    J Gen Virol. 2020 Jun 10. doi: 10.1099/jgv.0.001449.
    >> Share

    May 2020
  47. MAO L, Liang P, Li W, Zhang S, et al
    Exosomes promote caprine parainfluenza virus type 3 infection by inhibiting autophagy.
    J Gen Virol. 2020 May 19. doi: 10.1099/jgv.0.001424.
    >> Share

  48. MAJID NN, Omar AR, Mariatulqabtiah AR
    Negligible effect of chicken cytokine IL-12 integration into recombinant fowlpox viruses expressing avian influenza virus neuraminidase N1 on host cellular immune responses.
    J Gen Virol. 2020 May 19. doi: 10.1099/jgv.0.001428.
    >> Share

  49. EIDEN S, Dijkman R, Zell R, Fuchs J, et al
    Using a mouse-adapted A/HK/01/68 influenza virus to analyse the impact of NS1 evolution in codons 196 and 231 on viral replication and virulence.
    J Gen Virol. 2020 May 14. doi: 10.1099/jgv.0.001422.
    >> Share

    April 2020
  50. QIN Z, Qu X, Lei L, Xu L, et al
    Y-Box-Binding Protein 3 (YBX3) Restricts Influenza A Virus by Interacting with Viral Ribonucleoprotein Complex and Imparing its Function.
    J Gen Virol. 2020;101:385-398.
    >> Share

    March 2020
  51. MURR M, Karger A, Steglich C, Mettenleiter TC, et al
    Coexpression of soluble and membrane-bound avian influenza virus H5 by recombinant Newcastle disease virus leads to an increase in antigen levels.
    J Gen Virol. 2020 Mar 25. doi: 10.1099/jgv.0.001405.
    >> Share

    February 2020
  52. BRANTTIE JM, Dutch RE
    Parainfluenza virus 5 fusion protein maintains pre-fusion stability but not fusogenic activity following mutation of a transmembrane leucine/isoleucine domain.
    J Gen Virol. 2020 Feb 25. doi: 10.1099/jgv.0.001399.
    >> Share

    December 2019
  53. TEPPER V, Nykvist M, Gillman A, Skog E, et al
    Influenza A/H4N2 mallard infection experiments further indicate zanamivir as less prone to induce environmental resistance development than oseltamivir.
    J Gen Virol. 2019 Dec 19. doi: 10.1099/jgv.0.001369.
    >> Share

    November 2019
  54. BROWN JC, Barclay WS, Galiano M, Harvey R, et al
    Passage of influenza A/H3N2 viruses in human airway cells removes artefactual variants associated with neuraminidase-mediated binding.
    J Gen Virol. 2019 Nov 8. doi: 10.1099/jgv.0.001348.
    >> Share

    September 2019
  55. HIRST JC, Hutchinson EC
    Single-particle measurements of filamentous influenza virions reveal damage induced by freezing.
    J Gen Virol. 2019 Sep 26. doi: 10.1099/jgv.0.001330.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016